SCHEMBL16338591

SCHEMBL16338591

COc1cc(CSC)cc(-n2on2-c2cc(CSC)cc(OC)c2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 1/20 0.40
▸ NOS1 P29475 1/20 0.40
▸ NOS2 P35228 1/20 0.40
▸ CYP19A1 P11511 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ CYP2E1 P05181 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C8 P10632 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2B6 P20813 1/20 0.35
▸ BRS3 P32247 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CALM1 P0DP23 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14785310 0.82 NOS3 (0.37) NOS3NOS1NOS2CYP19A1TSHR
SCHEMBL18896261 0.81 ALDH1A1 (0.52) NOS3NOS1NOS2CYP19A1TSHR
SCHEMBL15719436 0.75 — —
SCHEMBL10204879 0.74 TACR1 (0.42) NOS3NOS1NOS2CYP19A1TSHR
SCHEMBL14793387 0.73 CYP19A1 (0.46) NOS3NOS1NOS2CYP19A1TSHR
SCHEMBL14793355 0.71 NOS3 (0.39) NOS3NOS1NOS2CYP19A1TSHR
SCHEMBL1145638 0.71 CYP1A2 (0.58) CYP1A2CMA1TP53POLBSIGMAR1
SCHEMBL18433895 0.69 KMT2A (0.38) NOS3NOS1NOS2TSHRMAPK1
SCHEMBL18433896 0.69 NOS3 (0.37) NOS3NOS1NOS2CYP19A1TSHR
SCHEMBL1145768 0.69 IDO1 (0.57) NOS3NOS1NOS2TSHRCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2755948-B1 DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP BAYER IP GMBH (DE) 2016-05-25 — — EP disclosed
US-9133171-B2 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-09-15 — — US disclosed
US-20150005329-A1 DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005329-A1 DISUBSTITUTED 5-FLUORO PYRIMIDINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP DHFR, DPYD, TYMP NOS3 1148/4885NOS1 976/4885NOS2 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback